Related Experiment Videos
The candidate Wilms' tumour gene is involved in genitourinary development
K Pritchard-Jones1, S Fleming, D Davidson
1Medical Research Council Human Genetics Unit, Western General Hospital, Edinburgh, UK.
Nature
|July 12, 1990
Summary
A key Wilms' tumour gene, identified at 11p13, is crucial for kidney development. Its expression in developing kidneys and gonads suggests a role in both Wilms' tumour formation and associated genitourinary abnormalities.
Area of Science:
- Developmental Biology
- Cancer Genetics
- Molecular Biology
Background:
- Wilms' tumour is an embryonic kidney cancer linked to aberrant stem cell differentiation and tumor suppressor gene dysfunction.
- Patients often exhibit urinary tract and genital abnormalities, particularly in WAGR syndrome.
Purpose of the Study:
- To investigate the role of a candidate Wilms' tumour gene (WT1) in normal kidney development and tumorigenesis.
- To determine if WT1 mutations contribute to genitourinary abnormalities.
Main Methods:
- In situ messenger RNA hybridization on human embryonic and Wilms' tumour tissues.
- Analysis of gene expression patterns.
Main Results:
- The candidate Wilms' tumour gene (WT1) is specifically expressed in developing kidney structures (mesenchyme, renal vesicle, glomerular epithelium) and related embryonic tissues.
- Expression was also observed in the genital ridge, fetal gonad, and mesothelium.
- WT1 expression patterns correlate with sites of Wilms' tumour development and genitourinary structures.
Conclusions:
- The identified candidate gene is confirmed as a Wilms' tumour gene.
- Genitourinary abnormalities are likely pleiotropic effects of WT1 gene mutations.
- The WT1 gene plays a specific role in kidney development and broader functions in mesenchymal-epithelial transitions.